Shinpoong Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: -0.004x

Shinpoong Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Shinpoong Pharmaceutical Co Ltd (019175) has a cash flow conversion efficiency ratio of -0.004x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.15 Billion ≈ $-777.75K USD) by net assets (₩278.04 Billion ≈ $188.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shinpoong Pharmaceutical Co Ltd (2014–2025)

Cash flow conversion efficiency of Shinpoong Pharmaceutical Co Ltd from 2014 to 2025. This chart illustrates how Shinpoong Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Shinpoong Pharmaceutical Co Ltd (019175) stock price for real-time trading data and today's change.

Shinpoong Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Shinpoong Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shinpoong Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shinpoong Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see market value of Shinpoong Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Fondia Oyj HE:FONDIA	-0.113x
Playgram Co. Ltd KO:009810	0.002x
Advanced Connection Corporation Public Company Limited BK:ACC	-0.013x
Paragon Banking Group PLC LSE:PAG	-0.465x
Gumho NT Co Ltd KQ:130500	0.006x
Wanted Lab Inc. KQ:376980	0.031x
MYMBN Berhad KLSE:0280	-0.062x
Adore Beauty Group Ltd AU:ABY	0.043x

Annual Cash Flow Conversion Efficiency for Shinpoong Pharmaceutical Co Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Shinpoong Pharmaceutical Co Ltd from 2014 to 2025. Review 019175 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩270.73 Billion ≈ $183.47 Million	₩17.25 Billion ≈ $11.69 Million	0.064x	+208.54%
2024-12-31	₩258.09 Billion ≈ $174.90 Million	₩-15.15 Billion ≈ $-10.27 Million	-0.059x	+35.91%
2023-12-31	₩270.78 Billion ≈ $183.51 Million	₩-24.81 Billion ≈ $-16.81 Million	-0.092x	-14.59%
2022-12-31	₩330.76 Billion ≈ $224.15 Million	₩-26.44 Billion ≈ $-17.92 Million	-0.080x	+60.09%
2021-12-31	₩354.56 Billion ≈ $240.28 Million	₩-71.03 Billion ≈ $-48.13 Million	-0.200x	-473.78%
2020-12-31	₩374.33 Billion ≈ $253.68 Million	₩20.06 Billion ≈ $13.60 Million	0.054x	-42.08%
2019-12-31	₩209.13 Billion ≈ $141.72 Million	₩19.35 Billion ≈ $13.11 Million	0.093x	-40.11%
2018-12-31	₩207.48 Billion ≈ $140.61 Million	₩32.05 Billion ≈ $21.72 Million	0.154x	+219.87%
2017-12-31	₩210.11 Billion ≈ $142.39 Million	₩10.15 Billion ≈ $6.88 Million	0.048x	-44.76%
2016-12-31	₩216.85 Billion ≈ $146.96 Million	₩18.96 Billion ≈ $12.85 Million	0.087x	+72.25%
2015-12-31	₩194.86 Billion ≈ $132.05 Million	₩9.89 Billion ≈ $6.70 Million	0.051x	+20285.41%
2014-12-31	₩191.51 Billion ≈ $129.79 Million	₩-48.16 Million ≈ $-32.64K	0.000x	--

About Shinpoong Pharmaceutical Co Ltd

KO:019175 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$16.98 Million

₩25.05 Billion KRW

Market Cap Rank

#25468 Global

#1883 in Korea

Share Price

₩12580.00

Change (1 day)

-1.87%

52-Week Range

₩10690.00 - ₩27000.00

All Time High

₩242550.07